vs
Side-by-side financial comparison of Bilibili Inc. (BILI) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Bilibili Inc. is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.1× PERRIGO Co plc). Bilibili Inc. runs the higher net margin — 6.0% vs -127.8%, a 133.8% gap on every dollar of revenue. On growth, Bilibili Inc. posted the faster year-over-year revenue change (26.2% vs -2.5%). Over the past eight quarters, Bilibili Inc.'s revenue compounded faster (27.3% CAGR vs 1.3%).
Bilibili, nicknamed B Site, is a Chinese online video sharing website based in Shanghai where users can submit, view, and add overlaid commentary on videos.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BILI vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $75.7M | $-1.4B |
| Gross Margin | 37.0% | 32.6% |
| Operating Margin | 5.8% | -116.0% |
| Net Margin | 6.0% | -127.8% |
| Revenue YoY | 26.2% | -2.5% |
| Net Profit YoY | 143.0% | -3093.9% |
| EPS (diluted) | $1.14 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $1.0B | $1.1B | ||
| Q1 25 | $965.1M | $1.0B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $843.1M | $1.1B | ||
| Q1 24 | $784.5M | $1.1B |
| Q4 25 | $75.7M | $-1.4B | ||
| Q3 25 | $65.9M | $7.5M | ||
| Q2 25 | $30.5M | $-8.4M | ||
| Q1 25 | $-1.5M | $-6.4M | ||
| Q4 24 | $-176.0M | $-44.4M | ||
| Q3 24 | $11.4M | $-21.0M | ||
| Q2 24 | $83.7M | $-108.4M | ||
| Q1 24 | $-105.9M | $2.0M |
| Q4 25 | 37.0% | 32.6% | ||
| Q3 25 | 36.7% | 36.1% | ||
| Q2 25 | 36.5% | 34.4% | ||
| Q1 25 | 36.3% | 37.6% | ||
| Q4 24 | 36.2% | 33.9% | ||
| Q3 24 | 34.9% | 37.2% | ||
| Q2 24 | 29.9% | 37.0% | ||
| Q1 24 | 28.3% | 33.1% |
| Q4 25 | 5.8% | -116.0% | ||
| Q3 25 | 4.6% | 7.0% | ||
| Q2 25 | 3.4% | 4.3% | ||
| Q1 25 | 0.2% | 4.5% | ||
| Q4 24 | -16.0% | 10.0% | ||
| Q3 24 | 0.9% | 7.4% | ||
| Q2 24 | 9.5% | -2.5% | ||
| Q1 24 | -14.5% | -5.1% |
| Q4 25 | 6.0% | -127.8% | ||
| Q3 25 | 6.1% | 0.7% | ||
| Q2 25 | 3.0% | -0.8% | ||
| Q1 25 | -0.2% | -0.6% | ||
| Q4 24 | -17.5% | -3.9% | ||
| Q3 24 | 1.1% | -1.9% | ||
| Q2 24 | 9.9% | -10.2% | ||
| Q1 24 | -13.5% | 0.2% |
| Q4 25 | $1.14 | $-10.23 | ||
| Q3 25 | $1.05 | $0.05 | ||
| Q2 25 | $0.51 | $-0.06 | ||
| Q1 25 | $0.00 | $-0.05 | ||
| Q4 24 | $0.21 | $-0.32 | ||
| Q3 24 | $-0.03 | $-0.15 | ||
| Q2 24 | $-0.20 | $-0.79 | ||
| Q1 24 | $-1.80 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.7B | — |
| Total DebtLower is stronger | $1.4B | — |
| Stockholders' EquityBook value | $2.2B | $2.9B |
| Total Assets | $5.9B | $8.5B |
| Debt / EquityLower = less leverage | 0.62× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.4B | $432.1M | ||
| Q2 25 | — | $454.2M | ||
| Q1 25 | $1.9B | $409.9M | ||
| Q4 24 | $1.8B | $558.8M | ||
| Q3 24 | $11.7B | $1.5B | ||
| Q2 24 | — | $542.8M | ||
| Q1 24 | $1.1B | $658.5M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $700.3M | — | ||
| Q4 24 | $662.5M | — | ||
| Q3 24 | $4.3B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $684.5M | — |
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.1B | $4.4B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | $2.0B | $4.4B | ||
| Q4 24 | $1.9B | $4.3B | ||
| Q3 24 | $13.7B | $4.6B | ||
| Q2 24 | — | $4.5B | ||
| Q1 24 | $1.9B | $4.7B |
| Q4 25 | $5.9B | $8.5B | ||
| Q3 25 | $5.6B | $10.1B | ||
| Q2 25 | — | $10.1B | ||
| Q1 25 | $4.6B | $9.8B | ||
| Q4 24 | $4.5B | $9.6B | ||
| Q3 24 | $32.0B | $11.2B | ||
| Q2 24 | — | $10.4B | ||
| Q1 24 | $4.2B | $10.6B |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $263.1M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 3.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $263.1M | $175.4M | ||
| Q3 25 | $283.2M | $51.7M | ||
| Q2 25 | $277.7M | $75.9M | ||
| Q1 25 | $179.4M | $-64.5M | ||
| Q4 24 | $191.9M | $312.6M | ||
| Q3 24 | $2.2B | $42.2M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | $88.3M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | $174.5M | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | — | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | 18.1% | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | — | -2.4% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | 0.5% | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | 3.47× | — | ||
| Q3 25 | 4.30× | 6.89× | ||
| Q2 25 | 9.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 195.23× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BILI
| Value-added services (VAS) | $466.4M | 37% |
| Advertising | $435.0M | 34% |
| Mobile games | $220.3M | 17% |
| Other | $80.8M | 6% |
| IP derivatives and others | $68.2M | 5% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
